Marshall Wace, LLP Clear Point Neuro, Inc. Transaction History

Marshall Wace, LLP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$11.89 - $18.8 $889,146 - $1.41 Million	74,781 Added 581.82%	87,634 $1.04 Million
Q4 2024 Feb 13, 2025	SELL	$10.74 - $16.68 $2.83 Million - $4.4 Million	-263,779 Reduced 95.35%	12,853 $197,000
Q3 2024 Nov 14, 2024	BUY	$5.3 - $13.18 $1.16 Million - $2.88 Million	218,372 Added 374.82%	276,632 $3.1 Million
Q2 2024 Aug 14, 2024	BUY	$5.25 - $6.73 $204,666 - $262,362	38,984 Added 202.24%	58,260 $314,000
Q1 2024 May 15, 2024	BUY	$6.03 - $7.86 $116,234 - $151,509	19,276 New	19,276 $131,000
Q2 2023 Aug 14, 2023	BUY	$6.54 - $10.58 $172,472 - $279,015	26,372 New	26,372 $190,000
Q4 2022 Feb 14, 2023	BUY	$7.7 - $11.21 $138,954 - $202,295	18,046 New	18,046 $152,000
Q2 2022 Aug 15, 2022	SELL	$7.09 - $13.65 $227,113 - $437,250	-32,033 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.8 - $11.6 $206,949 - $307,771	-26,532 Reduced 45.3%	32,033 $333,000
Q4 2021 Feb 14, 2022	BUY	$11.08 - $18.86 $24,087 - $41,001	2,174 Added 3.86%	58,565 $657,000
Q2 2021 Aug 13, 2021	BUY	$17.23 - $22.77 $971,616 - $1.28 Million	56,391 New	56,391 $1.08 Million

102

7.91M

116K

46.8K

Ticker CLPT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,488,300
Market Cap $258M
Description
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.